Adani Group Stocks in Focus PL Capital Highlights Growth Potential in Infrastructure and Energy Microsoft Reports Highlight AI Cost Conundrum Automation May Outweigh Human Wages in Expense April Jobs Report Preview Labor Market Cooling but Resilient Economists Say Norway Scales Up Oil and Gas Production as Europe Seeks Energy Alternatives AIRelated Layoffs Not Necessarily a Boost for Stocks GlobalFoundries Strong Q1 Performance Signals Growth Inflection Say Meridian Fund Managers OPRT Q1 2026 Earnings EPS Surpasses Estimates by 243 Despite Stock Decline KRP Q1 2026 Earnings Steep Earnings Miss Amid Challenging Environment JILL Q1 2026 Earnings EPS Beats Estimates Despite Loss Stock Rises Chime Financial Inc CHYM Q1 2026 Earnings Robust EPS Beat Defies Market Skepticism PPC Q1 2026 Earnings EPS Miss Hits Investor Sentiment as Profit Falls Short of Estimates RNGR Q1 2026 Earnings EPS Misses Estimates by Nearly 39 Amid Operational Headwinds BlackRock Health Sciences Term Trust BMEZ Edges Higher as Sector Rotation Continues SRX Health Solutions SRXH Declines 55 as Stock Tests Key Support at 011 US Physical Therapy USPH Gains 332 as Stock Tests Resistance Levels Nextdoor Holdings NXDR Slips Near Support as Trading Volatility Persists Transcontinental Realty Investors TCI Edges Higher in Quiet Session as Support Holds Spring Homebuyers Face Hefty Seller Premiums May and June Could Be the Costliest Months Meridian Corporation MRBK Q1 2026 Earnings EPS Misses Estimates but Stock Gains Slightly TPG RE Finance Trust TRTX Holds Steady Near Support as Commercial Real Estate Sentiment Shifts EZRA Q1 2023 Earnings Massive EPS Beat Drives Stock Surge ABCL Q1 2026 Earnings EPS Surprises to the Upside as Biotech Continues Development MH Q1 2026 Earnings Massive EPS Beat Fails to Lift Stock EDN Q4 2024 Earnings Massive EPS Surprise Masks Broader Concerns as Stock Declines GIII Q1 2026 Earnings EPS Misses Estimates as Apparel Group Faces Margin Pressure Brilliant Earth Group Inc BRLT Q1 2026 Earnings EPS Misses Estimates But Stock Rises on Operational Developments Vistagen Therapeutics VTGN Q1 2026 Earnings Narrowing Loss Beats Estimates as Pipeline Progress Continues